Article Details
Retrieved on: 2022-12-18 14:08:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech SE (NASDAQ:BNTX) announced plans today for a clinical trial hub in Taiwan for its MRNA-based cancer immunotherapies. The move comes as p.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here